BRIELLA VILLENA: Open Payments
NPI 1093431975 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 32 payments from 10 companies in 2025. Trend: 2023 $1,168 · 2024 $898 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $183 |
| Alnylam Pharmaceuticals Inc. | 5 | $149 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Merck Sharp & Dohme LLC | 4 | $91 |
| BridgeBio Pharma, Inc. | 3 | $82 |
| CVRx, Inc. | 1 | $33 |
| Kestra Medical Technology Services, Inc. | 1 | $30 |
| SCPHARMACEUTICALS INC. | 1 | $27 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $25 |
| Veloxis Pharmaceuticals, Inc. | 1 | $20 |
Products named: JARDIANCE, AMVUTTRA, WAINUA, Attruby, VERQUVO, LOKELMA, Barostim Neo System, Assure WCD.
Industry payments across NY — which companies pay providers there.
